BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23977378)

  • 1. Forchlorfenuron disrupts SEPT9_i1 filaments and inhibits HIF-1.
    Vardi-Oknin D; Golan M; Mabjeesh NJ
    PLoS One; 2013; 8(8):e73179. PubMed ID: 23977378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SEPT9_i1 is required for the association between HIF-1α and importin-α to promote efficient nuclear translocation.
    Golan M; Mabjeesh NJ
    Cell Cycle; 2013 Jul; 12(14):2297-308. PubMed ID: 24067372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted knockdown of SEPT9_v1 inhibits tumor growth and angiogenesis of human prostate cancer cells concomitant with disruption of hypoxia-inducible factor-1 pathway.
    Amir S; Golan M; Mabjeesh NJ
    Mol Cancer Res; 2010 May; 8(5):643-52. PubMed ID: 20407014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of hypoxia-inducible factor 1α and septin 9 interaction by bimolecular fluorescence complementation in live cancer cells.
    Golan M; Mabjeesh NJ
    Oncotarget; 2017 May; 8(19):31830-31841. PubMed ID: 28380438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Septin 9 isoform 1 (SEPT9_i1) specifically interacts with importin-α7 to drive hypoxia-inducible factor (HIF)-1α nuclear translocation.
    Tazat K; Schindler S; Depping R; Mabjeesh NJ
    Cytoskeleton (Hoboken); 2019 Jan; 76(1):123-130. PubMed ID: 29742803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Septin Cytoskeleton-Targeting Small Molecule, Forchlorfenuron, Inhibits Epithelial Migration via Septin-Independent Perturbation of Cellular Signaling.
    Sun L; Cao X; Lechuga S; Feygin A; Naydenov NG; Ivanov AI
    Cells; 2019 Dec; 9(1):. PubMed ID: 31905721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Off-target effects of the septin drug forchlorfenuron on nonplant eukaryotes.
    Heasley LR; Garcia G; McMurray MA
    Eukaryot Cell; 2014 Nov; 13(11):1411-20. PubMed ID: 25217460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SEPT9_v1 up-regulates hypoxia-inducible factor 1 by preventing its RACK1-mediated degradation.
    Amir S; Wang R; Simons JW; Mabjeesh NJ
    J Biol Chem; 2009 Apr; 284(17):11142-51. PubMed ID: 19251694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of nuclear translocation of hypoxia-inducible factor-1α in influenza A (H1N1) virus infected-alveolar epithelial cells].
    Meng X; Guo X; Zhu Y; Xie H; Wang R
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):8-13. PubMed ID: 32148224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forchlorfenuron alters mammalian septin assembly, organization, and dynamics.
    Hu Q; Nelson WJ; Spiliotis ET
    J Biol Chem; 2008 Oct; 283(43):29563-71. PubMed ID: 18713753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oltipraz and dithiolethione congeners inhibit hypoxia-inducible factor-1alpha activity through p70 ribosomal S6 kinase-1 inhibition and H2O2-scavenging effect.
    Lee WH; Kim YW; Choi JH; Brooks SC; Lee MO; Kim SG
    Mol Cancer Ther; 2009 Oct; 8(10):2791-802. PubMed ID: 19789218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Potent Forchlorfenuron Analogs and Their Cytotoxic Effect in Cancer Cell Lines.
    Kim KK; Singh RK; Khazan N; Kodza A; Singh NA; Jones A; Sivagnanalingam U; Towner M; Itamochi H; Turner R; Moore RG
    Sci Rep; 2020 Feb; 10(1):3241. PubMed ID: 32094384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Septin oligomerization regulates persistent expression of ErbB2/HER2 in gastric cancer cells.
    Marcus EA; Tokhtaeva E; Turdikulova S; Capri J; Whitelegge JP; Scott DR; Sachs G; Berditchevski F; Vagin O
    Biochem J; 2016 Jun; 473(12):1703-18. PubMed ID: 27048593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular requirements for the small molecule forchlorfenuron to stabilize the septin cytoskeleton.
    DeMay BS; Meseroll RA; Occhipinti P; Gladfelter AS
    Cytoskeleton (Hoboken); 2010 Jun; 67(6):383-99. PubMed ID: 20517926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SEPT9_i1 regulates human breast cancer cell motility through cytoskeletal and RhoA/FAK signaling pathway regulation.
    Zeng Y; Cao Y; Liu L; Zhao J; Zhang T; Xiao L; Jia M; Tian Q; Yu H; Chen S; Cai Y
    Cell Death Dis; 2019 Sep; 10(10):720. PubMed ID: 31558699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MSF-A interacts with hypoxia-inducible factor-1alpha and augments hypoxia-inducible factor transcriptional activation to affect tumorigenicity and angiogenesis.
    Amir S; Wang R; Matzkin H; Simons JW; Mabjeesh NJ
    Cancer Res; 2006 Jan; 66(2):856-66. PubMed ID: 16424018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
    Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico docking of forchlorfenuron (FCF) to septins suggests that FCF interferes with GTP binding.
    Angelis D; Karasmanis EP; Bai X; Spiliotis ET
    PLoS One; 2014; 9(5):e96390. PubMed ID: 24787956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasudil-induced hypoxia-inducible factor-1alpha degradation disrupts a hypoxia-driven vascular endothelial growth factor autocrine mechanism in endothelial cells.
    Takata K; Morishige K; Takahashi T; Hashimoto K; Tsutsumi S; Yin L; Ohta T; Kawagoe J; Takahashi K; Kurachi H
    Mol Cancer Ther; 2008 Jun; 7(6):1551-61. PubMed ID: 18566226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition.
    Chintala S; Najrana T; Toth K; Cao S; Durrani FA; Pili R; Rustum YM
    BMC Cancer; 2012 Jul; 12():293. PubMed ID: 22804960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.